Dimension Therapeutics Sets Terms for IPO
Dimension Therapeutics expects to offer 5.5 million shares within the price range of $14 to $16 in an IPO valued up to $101.2 million.
All Work
Chris Lange
Why Key Analyst Sees iRobot as a Solid Buy
Considering weakness over the past year and a recent rally, one key analyst sees iRobot in a prime opportunity to buy going into the fourth quarter.
What Twitter Layoffs Mean Versus Its Valuation
In one of his first moves as the permanent Twitter chief executive officer, Jack Dorsey is laying off a few hundred employees.
Ryder Tumbles on Updated Guidance
Courtesy of RyderRyder System, Inc. (NYSE: R) took a sharp downturn after the markets closed on Monday following the release of updated guidance. The company revised its earnings guidance for the third quarter and…
How a Key Analyst Sees Semiconductors Closing Out 2015
Credit Suisse's John Pitzer has issued his pre-earnings outlook for the semiconductor sector.
Meet Chipotle’s Newest Addition to Its Executive Team
Chipotle Mexican Grill, Inc. (NYSE: CMG) is making waves in the market on Monday after it announced that it would be adding to its executive staff. The company announced the hiring of Curt Garner…
What to Expect From Johnson & Johnson Earnings
Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.
Can-Fite Biopharma Does It Again With Orphan Drug Designation
Can-Fite Biopharma announced that its oncology drug candidate has been granted Orphan Drug Designation by the European Medicines Agency (EMA).
Interactive Data Gears Up for IPO
Interactive Data Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Short Sellers Continue Adding to Major Oil Positions
The September 30 short interest data have been compared with the previous figures, and short interest for the selected oil stocks increased almost across the board.
Short Sellers Become More Selective on Major Pharma
The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Short Sellers Continue to Have Mixed Stance on Semiconductors
On the broad scope, short sellers appeared to have mixed feelings on these semiconductor stocks as of the September 30 settlement date.
Short Sellers Increase Bets in Major Biotechs
The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected biotech stocks for this settlement date.
5 Major Earnings Reports Due This Week
We are just entering into earnings season in which most major companies will report and set a direction for the market.
Top Dow Earnings in the Coming Week
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Top 5 Bank Earnings to Look For in the Week Ahead
As the earnings season has just kicked off, we are now hailing some of the first reporters, which are the major banks.
CPI Card Enters the Market With a Bang
CPI Card Group debuted on the market in its initial public offering (IPO) on Thursday.
What May Drive GE to 52-Week and Multiyear Highs
GE stock is sitting just under a multiyear high and could stand to run even further, if it keeps up this solid momentum gained from recent catalysts.
SEC Comes Down on Chicago Firms on Misuse of Material Nonpublic Information
The SEC has charged Wolverine Trading and Wolverine Asset Management with failing to maintain and enforce policies and procedures to prevent the misuse of material nonpublic information.
Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher
Credit Suisse sees solid upside in this company Eli Lilly as the result of a strong pipeline, with its Alzheimer's candidate as a potential blockbuster.